Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Früh

Showing results (31-40 of 619) with videos related to

Pageof 62
Sort By:
Journal of Virology|April 29, 2005
Rhesus cytomegalovirus particles prevent activation of interferon regulatory factor 3Victor DeFilippis, Klaus Früh
European Journal of Immunology|February 12, 2000
A role for MHC class I down-regulation in NK cell lysis of herpes virus-infected cellsB Huard, K Früh
Medical Microbiology and Immunology|January 15, 2008
Rhesus CMV: an emerging animal model for human CMVColin Powers, Klaus Früh
Therapeutische Umschau. Revue Therapeutique|March 1, 1995
[Acute vertigo]A Bont, J Früh
Current Opinion in Immunology|July 23, 2017
CD8+ T cell programming by cytomegalovirus vectors: applications in prophylactic and therapeutic vaccinationKlaus Früh, Louis Picker
Science'S STKE : Signal Transduction Knowledge Environment|May 18, 2006
Viral modulators of cullin RING ubiquitin ligases: culling the host defenseMichele Barry, Klaus Früh
Genetic Counseling (Geneva, Switzerland)|January 1, 1990
Wilhelm Weinberg, M.D. (1862-1937): the man behind the "Hardy-Weinberg-equilibrium"J Süss, D Früh
Innere Medizin (Heidelberg, Germany)|March 26, 2026
[Severe pulmonary Mycobacterium genavense infection in an immunocompetent adult : Diagnostic challenges and successful macrolide-based combination therapy]Jonas Früh, Johanna Bolay, Raphaela Kalus, et al.
Biomaterials|August 28, 1998
Tribological investigations of the wear couple alumina-CFRP for total hip replacementH J Früh, G Willmann
Schweizerische Medizinische Wochenschrift|June 17, 1995
[Treatable immune-mediated neuropathies]A J Steck, J Früh
Pageof 62

Showing results (31-40 of 619) with videos related to

Sort By:
Pageof 62
Journal of Virology|April 29, 2005
Rhesus cytomegalovirus particles prevent activation of interferon regulatory factor 3Victor DeFilippis, Klaus Früh
European Journal of Immunology|February 12, 2000
A role for MHC class I down-regulation in NK cell lysis of herpes virus-infected cellsB Huard, K Früh
Medical Microbiology and Immunology|January 15, 2008
Rhesus CMV: an emerging animal model for human CMVColin Powers, Klaus Früh
Therapeutische Umschau. Revue Therapeutique|March 1, 1995
[Acute vertigo]A Bont, J Früh
Current Opinion in Immunology|July 23, 2017
CD8+ T cell programming by cytomegalovirus vectors: applications in prophylactic and therapeutic vaccinationKlaus Früh, Louis Picker
Science'S STKE : Signal Transduction Knowledge Environment|May 18, 2006
Viral modulators of cullin RING ubiquitin ligases: culling the host defenseMichele Barry, Klaus Früh
Genetic Counseling (Geneva, Switzerland)|January 1, 1990
Wilhelm Weinberg, M.D. (1862-1937): the man behind the "Hardy-Weinberg-equilibrium"J Süss, D Früh
Innere Medizin (Heidelberg, Germany)|March 26, 2026
[Severe pulmonary Mycobacterium genavense infection in an immunocompetent adult : Diagnostic challenges and successful macrolide-based combination therapy]Jonas Früh, Johanna Bolay, Raphaela Kalus, et al.
Biomaterials|August 28, 1998
Tribological investigations of the wear couple alumina-CFRP for total hip replacementH J Früh, G Willmann
Schweizerische Medizinische Wochenschrift|June 17, 1995
[Treatable immune-mediated neuropathies]A J Steck, J Früh
Pageof 62